Health crisis whacks TB efforts
He was still on the waiting list in March 2008 when he fell ill and was diagnosed with tuberculosis (TB). He completed a six-month course of treatment, but the TB returned three months later and his health has not improved since he started the medication.
Paraziva’s doctors suspect he has become resistant to one or more of the drugs he is taking, but there is no way of confirming this. Zimbabwe’s public health sector has been in a state of collapse for months; government laboratories equipped to run drug sensitivity tests are not functioning, and most of the experienced laboratory technicians have left the country or moved into the private sector.
“I had been asked to take my sputum to the private sector but these tests are very expensive and I have no money,” he said. “I am afraid I may not make it this time. I am not responding to treatment, but without the necessary tests they cannot tell which drug or drugs I am resistant to.”
Many TB patients who depend on state hospitals for treatment share Paraziva’s predicament. Zimbabwe’s health system crisis, the result of years of underfunding and a political and economic crisis that has affected every sector of society, has all but wiped out TB control efforts; measures to contain and treat cases of drug-resistant TB, such as Paraziva may be suffering from, have been neglected.
According to the 2009 Global TB Control Report released on Tuesday by the World Health Organization (WHO), Zimbabwe has the fourth highest incidence of TB in the world. Unlike most other high-burden countries, which have been steadily improving their rates of diagnosing and successfully treating TB, Zimbabwe’s have been declining.
Only 60 percent of TB patients diagnosed in 2007 were successfully treated, down from 68 percent the year before and well below the target of 85 percent recommended by WHO. Even more worryingly, only an estimated 27 percent of cases were diagnosed, down from 55 percent a decade ago.
The WHO report also highlighted a significant and growing gap between the cost of addressing Zimbabwe’s TB epidemic and the money available to do so.
“The TB control programme has been adversely affected by a lack of adequate financial, human and material resources,” the report noted. The country’s recording and reporting system was also unable to provide reliable data for several aspects of the TB programme, including the management of multidrug- resistant TB (MDR-TB).
As in many sub-Saharan countries, the re-emergence of TB as a major public health problem in Zimbabwe is strongly linked to the HIV epidemic; an estimated 69 percent of TB patients are co-infected with HIV.
A grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria is expected to help revive basic TB control efforts, said the report, “However, without a functional health-care system, progress is likely to be slow.”
Dr Owen Mugurungi, the National TB and HIV coordinator, told IRIN/PlusNews that in the context of the many challenges facing Zimbabwe, the country was doing its best to control TB.
“We have recorded cases of MDR [-TB] in Zimbabwe. The figures at national level are not yet available, but it must be noted that where resistance develops it is mostly because a patient fails to adhere to treatment and, as authorities, we can only go as far as counsel and stress on this issue,” said Mugurungi.
“For MDR-TB, a patient is moved from first-line treatment to second-line, but this second-line treatment is very expensive and not readily available.”
Paraziva, who never accessed second-line treatment, died on Tuesday, 24 March.
This feature is used with permission from IRIN/PlusNews – www.plusnews.org
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Health crisis whacks TB efforts
by Health-e News, Health-e News
March 25, 2009